by Zydus cadila
Save 19%
Original price
Rs. 99,360.00
Original price
Rs. 99,360.00
-
Original price
Rs. 99,360.00
Original price
Rs. 99,360.00
Current price
Rs. 80,425.00
Rs. 80,425.00
-
Rs. 80,425.00
Current price
Rs. 80,425.00
Brixta 400 Injection is an anti-cancer medication. It is used in the treatment of cancer of colon and rectum, non-small cell lung cancer, kidney cancer, brain tumor, ovarian and cervical cancer. It helps prevent the growth of new blood vessels that feed the tumor and stop the tumor from growing.
Bryxta 400 Injection is an effective medicine, first-line option when used together with other cancer medicines. It is given as an infusion. That means you get it through a small needle in your vein or through a port, which is a device placed under your skin. The doctor will decide your dose and duration and will check you for signs of an infusion reaction such as high blood pressure and trouble breathing. You keep taking Bryxta 400 Injection as long as your disease is controlled and your side effects are manageable. Your doctor will determine whether you should stop taking it or not. You may be advised to check blood pressure and levels of protein in urine while you are taking this medication.
The most common side effects of this medicine include rectal bleeding, altered taste, and headache. Before undergoing any surgical procedure, inform your doctor that you are taking this medicine, as the medicine has the potential to reduce wound healing. Additionally, it also increases your risk of bleeding so consult your doctor immediately if you notice any unusual bleeding or spotting.
Tell your doctor if you are pregnant, planning pregnancy, or breastfeeding. Many other medicines can affect, or be affected by, this medicine, so tell your healthcare team about all the medicines you use. Tell us about what you are using.
Bryxta 400 Injection is an effective medicine, first-line option when used together with other cancer medicines. It is given as an infusion. That means you get it through a small needle in your vein or through a port, which is a device placed under your skin. The doctor will decide your dose and duration and will check you for signs of an infusion reaction such as high blood pressure and trouble breathing. You keep taking Bryxta 400 Injection as long as your disease is controlled and your side effects are manageable. Your doctor will determine whether you should stop taking it or not. You may be advised to check blood pressure and levels of protein in urine while you are taking this medication.
The most common side effects of this medicine include rectal bleeding, altered taste, and headache. Before undergoing any surgical procedure, inform your doctor that you are taking this medicine, as the medicine has the potential to reduce wound healing. Additionally, it also increases your risk of bleeding so consult your doctor immediately if you notice any unusual bleeding or spotting.
Tell your doctor if you are pregnant, planning pregnancy, or breastfeeding. Many other medicines can affect, or be affected by, this medicine, so tell your healthcare team about all the medicines you use. Tell us about what you are using.
USES OF BRIXTA INJECTION
- colon and rectal cancer
- Non-small cell lung cancer
- kidney cancer
- brain tumor
- ovarian cancer
- cervical cancer
BENEFITS OF BRIXTA INJECTION
Colon and rectal cancer
Colorectal cancer (CRC) or cancer of the colon and rectum, also known as bowel cancer, is the development of cancer from two parts of the large intestine, namely, the colon or rectum. In this type of cancer, symptoms like blood in stool, change in bowel movement, weight loss and fatigue can be seen. Bryxta 400 Injection treats and also lowers the risk of developing further cancerous growths (polyps) and bowel cancer. It stops the growth of cancer cells and kills them and increases the number of cancer cells. This is an effective, yet very toxic drug and you should talk with your doctor about its risks and benefits.
In non-small cell lung cancer
Non-small cell lung cancer is one of the leading types of lung cancer and affects both smokers and non-smokers. Brixta 400 Injection helps treat non-small cell lung cancer and may be given alone or in combination with other medicines. This is a very effective and toxic drug and you should talk to your doctor about its risks and benefits. One should avoid drinking alcohol or smoking during this treatment and drink plenty of water to stay hydrated.
in kidney cancer
Brixta 400 Injection is used to treat kidney cancer and its associated symptoms such as blood in urine, unexplained low back pain or weight loss, fatigue, loss of appetite etc. It stops the growth of cancer and multiplication of cancer cells. This restricts the progression of cancer to other unaffected organs. To recover, you have to follow your doctor's instructions very carefully.
in brain tumor
A brain tumor is an abnormal group or collection of cells and may be cancerous (malignant) or non-cancerous (benign). Brixta 400 Injection kills or stops the growth of cancer cells and also prevents the spread of cancer cells. Consult your doctor if you have any doubts.
in ovarian cancer
Ovarian cancer is a type of cancer that begins in the female genital organs (ovaries) that produce eggs. This type of cancer is usually detected very late and can also be fatal. It usually spreads to the pelvis and abdomen. Brixta 400 Injection kills or stops the growth of cancer cells and also prevents the spread of cancer cells. It is an effective medicine but it may have some side effects which can be troublesome. Therefore, you should talk to your doctor about the risks and benefits.
in cervical cancer
Bryxta 400 Injection is an anti-cancer medicine that is used to kill cancerous cells in cervical cancer, a cancer that develops in the cervix of a female. Affected women may have symptoms such as abnormal bleeding, foul-smelling vaginal discharge, lower back pain, or may have no symptoms. It has a number of side effects and you should talk to your doctor about the risks and benefits before starting treatment with this medicine.